Perfil epidemiológico dos pacientes com síndrome vertiginosa atendidos no ambulatório de otorrinolaringologia do Centro de Especialidades Médicas do Cesupa (CEMEC) de 2015 a 2017

Abstract

Introduction: Vertigo is a disabling symptom, with direct repercussions on the patient´s life, and has a significant prevalence. especially with the advancing age. Objective: To determine the epidemiological profile of patients with vertigo attended at the Otorhinolaryngology outpatient clinic of the CESUPA Medical Specialties Center (CEMEC). Method: This is a cross-sectional and descriptive study, based on the review of medical records of patients with vertigo attended at the Otorhinolaryngology outpatient clinic of the Center of Medical Specialties of CESUPA (CEMEC), between 2015 and 2017. The data analyzed included: age, gender, race, marital status, type of vertigo, previous treatment, presence of other clinical manifestations and etiological diagnosis of vertigo syndrome. Results: Females were the most prevalent with 91.4% of the individuals, and the age range between 61 and 70 years represented the highest prevalence with 41.4% of the total. As for comorbidities, 52.9% of the individuals did not present comorbidities and 47.1% had comorbidities, 46.1% had systemic arterial hypertension and 40.4% had dyslipidemia. When assessing the clinical manifestations, the most prevalent were imbalance, tinnitus and headache. No cases of paresis, diplopia and dysarthria were observed. Regarding the type of vertigo, 94% presented vertigo of peripheral origin and 6% of central origin. Of the individuals with central vertigo, 50% had vestibular migraine, 25% cerebrovascular accident or brainstem and 25% undetermined. In relation to the diagnosis of peripheral vertigo, 45.4% of the individuals presented benign paroxysmal positional vertigo (BPPV), 6.1% of the individuals presented Ménière's disease, 6.1% bacterial labyrinthitis and 42.4% undetermined. Regarding drug treatment for vertigo, 51.4% of patients used drugs as therapy once at time, 7% used dimenhydrate, 4.2% of the subjects used betahistine, 41.8% flunarizine and 7% other treatments. There was no significant difference between the factors evaluated about the treatment (p value> 0.05). Conclusion: Vertigo is a more common pathology in females and associated with advancing age, which requires careful clinical investigation. It may have an important impact on the quality of life and need pharmacological therapy. The most prevalent causes are those with peripheral etiology and benign paroxysmal positional vertigo (BPPV), which is the most common.